Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Antiemetics dosing regimens for)
121 results
  • Targeting histone deacetylases in T-cell lymphoma. [Review]
  • LLLeuk Lymphoma 2017; 58(6):1306-1319
  • Moskowitz AJ, Horwitz SM
  • Histone deacetylase inhibitors (HDACi) are epigenetic modifiers with single-agent activity in patients with cutaneous and peripheral T-cell lymphoma (CTCL, PTCL). The mechanisms for this preferential...
  • Different oral corticosteroid regimens for acute asthma. [Review]
  • CDCochrane Database Syst Rev 2016; (5):CD011801
  • Normansell R, Kew KM, Mansour G
  • CONCLUSIONS: Evidence is not strong enough to reveal whether shorter or lower-dose regimens are generally less effective than longer or higher-dose regimens, or indeed that the latter are associated with more adverse events. Any changes recommended for current practice should be supported by data from larger, well-designed trials. Varied study design and outcome measures limited the number of meta-analyses that we could perform. Greater emphasis on palatability and on whether some regimens might be easier to adhere to than others could better inform clinical decisions for individual patients.
New Search Next